US OptionsDetailed Quotes
BCYC241220C2500
- 0.00
- 0.000.00%
15min DelayClose Dec 2 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover686.74%IV-87.51%PremiumDec 20, 2024Expiry Date17.51Intrinsic Value100Multiplier17DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9836Delta0.0014Gamma1.12Leverage Ratio-0.0351Theta0.0009Rho1.10Eff Leverage0.0018Vega
Bicycle Therapeutics Stock Discussion
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$
...
⇨ held by 5 biopharma-focused hedge funds! 🔥
$Arcellx (ACLX.US)$ : Anito-cel (Ph 2)
$Adaptimmune Therapeutics (ADAP.US)$ : Afami-cel (PDUFA) ⏳
$Bicycle Therapeutics (BCYC.US)$ : BT8009 (Ph 1/2)
$Centessa Pharmaceuticals (CNTA.US)$ : LB101 (Ph 1/2)
$Day One Biopharmaceuticals (DAWN.US)$ : Tovorafenib (PDUFA) (check comments for details)
$Fate Therapeutics (FATE.US)$ : FT576 (Ph 1)
$Fusion Pharmaceuticals (FUSN.US)$ : FPI-2265 (Ph 2)
$GRCL: ...
Bicycle Therapeutics' Lead Candidate BT8009 For Metastatic Bladder (Urothelial) Cancer, Has Been Selected For Chemistry, Manufacturing And Controls Development And Readiness Pilot Program Launched By FDA
In reaction to earnings/guidance:
• $Coupa Software (COUP.US)$ +12% (also authorizes new $100mln share repurchase program), $REV Group (REVG.US)$ -5%, $G-III Apparel Group (GIII.US)$ + 2.1%, $Gitlab (GTLB.US)$ +1.2%
Other news:
• $Tupperware Brands (TUP.US)$ +6.7% (recovers a bit after falling -33% during regular session)
• $Avaya Holdings (AVYA.US)$ +6.6% (authorizes workforce reduction plan)
• $Bassett Furniture Industries (BSET.US)$ +5% (acqu...
• $Red Robin (RRGB.US)$ +13.8% (In reaction to earnings)
• $PMV Pharmaceuticals (PMVP.US)$ +11.2% (ASCO-related announcement)
• $Sumo Logic (SUMO.US)$ +10.8% (In reaction to earnings)
• $Adicet Bio (ACET.US)$ +9.6% (ASCO-related announcement)
• $Dell Technologies (DELL.US)$ +9.6% (In reaction to earnings)
• $ImmunoGen (IMGN.US)$ +8.7% (ASCO-related announcement)
• $Ulta Beauty (ULTA.US)$ +7.9% (In reaction to earnings)
• $Zymergen (ZY.US)$ +7.8% (to...
No comment yet